Eisai Korea Inc.
Quick facts
Marketed products
- Aricept · Neuroscience
- Pariet · Other
- Safinamide Mesilate
- zonisamide high dose group · Neurology
Zonisamide is a sulfonamide anticonvulsant that reduces neuronal excitability by blocking sodium and calcium channels and enhancing GABAergic inhibition. - zonisamide low dose group · Neurology
Zonisamide inhibits multiple ion channels and carbonic anhydrase to reduce neuronal excitability and seizure activity.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Eisai Korea Inc.
What are Eisai Korea Inc.'s marketed drugs?
Top marketed products include Aricept, Pariet, Safinamide Mesilate, zonisamide high dose group, zonisamide low dose group.
Related
- Aricept · Neuroscience
- Pariet · Other
- Safinamide Mesilate
- zonisamide high dose group · Neurology
- zonisamide low dose group · Neurology
- Sector hub: All tracked pharma companies